Navigation Links
Optimer Pharmaceuticals Expands Senior Management Team
Date:5/3/2011

ll as the antifungal, antibacterial, vaccines, HIV and hepatitis C teams (including the development and recent filing of boceprevir).  Previously, Dr. Ruiz held several leadership roles at Bristol-Myers Squibb, where she gained global early and late clinical development and medical affairs experience in infectious diseases (HIV- Sustiva®, Reyataz®; hepatitis B-Baraclude®) and immunology (rheumatoid arthritis- Orencia® and transplant- belatacept).  Prior to initiating her career as a clinician and clinical investigator, Dr. Ruiz received her B.A. at Temple University in Philadelphia and her M.D. at the Ponce School of Medicine in Puerto Rico.  She is a Diplomat of the American Board of Internal Medicine and the American Board of Infectious Diseases and a Fellow of the American College of Physicians and Fellow of the Infectious Diseases Society of America.

Ms. Schwalm brings a strong track record of growth and development in hospital and specialty markets during her 30 years of experience in the fields of pharmaceuticals, biotechnology, medical devices and health care delivery. She joins Optimer from Eisai Pharmaceuticals, Inc., the U.S. commercial arm of Tokyo-based Eisai Co., LTD, where she served as President. Ms. Schwalm had full operating responsibilities for Eisai Pharmaceuticals where she led commercial, medical and manufacturing functions. Her team built independent commercial capabilities for Eisai and drove double digit top line and bottom line P&L growth during her tenure. She came to Eisai in 2008 from Amgen Inc. where, over the course of her five-year tenure, she rose to Vice President and General Manager of the U.S. oncology business.  Under her leadership, the unit's annual revenues tripled to over $5 billion, as she directed approximately 500 people in all areas of oncology strategy and commercialization.  Prior to Amgen, she spent 18 years at Johnson & Johnson holding positions of increasing
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Optimer Pharmaceuticals to Present at May 2011 Investor Conferences
2. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
3. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
4. Trading Halted Today in Optimer Pharmaceuticals Stock
5. Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
6. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
7. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
8. Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
9. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
10. Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
11. Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013  Boehringer Ingelheim will contribute ... at the American Thoracic Society International Conference (ATS ... May 17 – 22. Data will ... the treatment of chronic obstructive pulmonary disease (COPD) ... as investigational compounds for asthma, idiopathic pulmonary fibrosis ...
(Date:5/17/2013)... , May 17, 2013 Oramed ... of oral drug delivery systems, announced today that the ... the Company,s Investigational New Drug application(IND) for ORMD-0801, its ... to have the FDA clearance to proceed," stated ... upcoming trial is a major milestone for Oramed and ...
(Date:5/16/2013)... MECHELEN, Belgium , May 17, 2013 ... ABBV ) announced today an extension of ... Galapagos will fund and complete a Phase 2 program ... progression into Phase 3.  Upon successful completion of the ... $50 million.  The terms of the collaboration extension are ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... Inc. (Nasdaq: IPCM ), a leading national hospitalist physician group practice company, announced ... Wednesday, November 11, 2009 at the 2009 Annual Credit Suisse Health Care Conference in ... Event: 2009 Annual Credit ... Date: Wednesday, November ...
... SAN FRANCISCO, Nov. 4 VIA Pharmaceuticals, Inc. (Nasdaq: ... development of compounds for the treatment of cardiovascular and ... Vice President Research & Development will present "VIA-3196, a ... the Abstract Oral Session on Novel Biological Mechanisms of ...
Cached Medicine Technology:IPC The Hospitalist Company, Inc. to Present at the 2009 Annual Credit Suisse Health Care Conference 2VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 2VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 3VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 4
(Date:5/20/2013)... May 20, 2013 AURORA, Colo. – ... online accredited university, has developed a Bachelor of ... assess how they feel about continuing their education and ... print out the complimentary worksheet, respond to ten statements ... they rate on a BSN-readiness scale. , New industry ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Can you tell a ... to tell a joke? , Would you like to be funnier ... sometimes feel like your funny bone is missing? , Can't think ... 2 hours later?     , If this sounds like you, don't worry. ... and develop their sense of humor; and even learn to tell ...
(Date:5/20/2013)... 2013 The transvaginal mesh lawyers at ... firm, report that two important bellwether trials are set ... and federal litigations established for C.R. Bard transvaginal ... C.R. Bard bellwether trial will begin in the federal ... Virginia. (In re: C.R. Bard, Inc., Pelvic Repair ...
(Date:5/20/2013)... May 20, 2013 Townsend Security, ... announced that the company’s Alliance Key Manager hardware ... with Key Connection for TrueCrypt for Windows ... strong passwords when using TrueCrypt for data protection. ... offer secure password management for TrueCrypt encryption. Today's ...
(Date:5/20/2013)... May 20, 2013 Gerald Wojtala, executive ... will speak at North Carolina Food Safety and Defense ... Business: The Need for Partnerships – from Farm to ... conference, scheduled for May 22-23 at the Sheraton Imperial ... the food sector have in protecting the food supply. ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 2Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 2Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 3Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 4Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 2Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 3Health News:IFPTI Executive Director to Speak at North Carolina Food Safety and Defense Task Force Annual Conference 2
... (ESMO) just released an enhanced and revised set ... the best quality care to their patients. ... vital, evidence-based information including the incidence of the ... assessment, treatment plans and follow-up. Formerly known ...
... precancers and cervical cancers is over 50 per cent more ... study in Mexico has revealed. Results of the largest ... a Latin American country point to the readiness of HPV ... online today (8 July 2010) in Cancer, Causes and ...
... ... Attract Most Eyeballs in June , ... Vancouver, BC, Canada (PRWEB) -- Suite101.com, a global content site that provides trusted and ... its site in June 2010, providing a window into consumer online reading behavior. In June, ...
... HealthDay Reporter , WEDNESDAY, July 7 (HealthDay News) ... may be able to control it more effectively on ... researchers contend. Through telemonitoring of their blood pressure ... in advance, patients assigned to self-managed care saw greater ...
... ... over the globe with their unbeatable embroidery and screen printing deals. New office space ... ... 2010 -- Uncle Sam can’t hold down this online apparel giant. Times may be ...
... , ... last week, funded by grants from the Mesothelioma Applied Research Foundation and the National ... in treatment and prevention of this aggressive and deadly cancer. , ... (PRWEB) July 8, 2010 -- Last ...
Cached Medicine News:Health News:ESMO publishes updated guidelines on cancer care 2Health News:ESMO publishes updated guidelines on cancer care 3Health News:HPV DNA testing over 50 percent more sensitive than cytology testing 2Health News:Suite 101.com Provides Insight Into Consumer Reading Behavior Online 2Health News:Suite 101.com Provides Insight Into Consumer Reading Behavior Online 3Health News:Suite 101.com Provides Insight Into Consumer Reading Behavior Online 4Health News:Monitoring Blood Pressure at Home May Help Keep It Low 2Health News:Monitoring Blood Pressure at Home May Help Keep It Low 3Health News:Clothing4all WOWs Yet Again With Customer Appreciation and Increased Sales 2Health News:Discovery Opens Door for New Options in Prevention and Treatment of Mesothelioma 2Health News:Discovery Opens Door for New Options in Prevention and Treatment of Mesothelioma 3
... with self-adjusting adaptability to fit almost every ... of angling at the sit of fixation ... permits it to be titled to any ... Intern®, a simple adjustment of the 3/D ...
Stainless steel construction to withstand sterilization modalities (EtO, Steris, and Sterrad)...
Inquire...
ENDOlap™ laparoscopes provide excellent image linearity and flatness of field....
Medicine Products: